loader
Please Wait
Applying Filters...
menu
    • menu

    Setid C43da258 73bb 4ca5 Bfe8 1c8a0500f91d Applno 19758 Form Tablet Oral Dosage 50mg - Drug Product Composition: Refraxol

    Menu

    Refraxol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 199Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 19758 / DOSAGE - TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CLOZAPINE(UNII: J60AR2IKIC)
    (CLOZAPINE - UNII:J60AR2IKIC)     		CLOZAPINE100mg

    Inactive Ingredients

    Ingredient Name
    Cardinal Health
    Novartis Pharmaceuticals Corporation
    Heartwood Pharma
    Sandoz Inc.
    LACTOSE(J2B2A4N98G)  
    Lactose, Unspecified Form(J2B2A4N98G)  
    MAGNESIUM STEARATE(70097M6I30)
    POVIDONE(FZ989GH94E)   
    Povidone, Unspecified(FZ989GH94E)  
    POVIDONES(FZ989GH94E)   
    SILICON DIOXIDE(ETJ7Z6XBU4)
    STARCH, CORN(O8232NY3SJ)
    TALC(7SEV7J4R1U)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.